Trends & Articles Revive Therapeutics Ltd. (OTCMKTS:RVVTF) Offers Update On Its Bucillamine Trial In COVID-19 Treatment By Larry Zweig March 22, 2021 Revive Therapeutics Ltd. (OTCMKTS:RVVTF) has announced an update on its US FDA third phase clinical study evaluating Bucillamine’s safety and efficacy in patients having mild-to moderated coronavirus. Revive expanding its Phase...